Mesirow Financial Investment Management, Inc. Vertex Pharmaceuticals Inc Transaction History
Mesirow Financial Investment Management, Inc.
- $4.9 Billion
- Q1 2025
A detailed history of Mesirow Financial Investment Management, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Mesirow Financial Investment Management, Inc. holds 629 shares of VRTX stock, worth $274,244. This represents 0.01% of its overall portfolio holdings.
Number of Shares
629
Previous 568
10.74%
Holding current value
$274,244
Previous $228,000
33.33%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding VRTX
# of Institutions
1,830Shares Held
233MCall Options Held
1.38MPut Options Held
1.08M-
Capital World Investors Los Angeles, CA28.5MShares$12.4 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$10.2 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.29 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$6.34 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.14 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $112B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...